IRADIMED CORP
For the period ended Dec 31, 2024. Filed Mar 6, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 6, 2025
IRMD$86.94+0.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Balance Sheets
| | | | | | |
|---|---|---|---|---|---|
| · December 31, · December 31, | |||||
| · 2024 · · 2023 | |||||
| ASSETS · · | |||||
| Current assets: · · | |||||
| Cash and cash equivalents | $52,233,907 | | $49,762,198 | ||
| Accounts receivable, net of allowance for credit losses of $274,300 as of December 31, 2024, and $368,835 as of December 31, 2023 | 10,556,733 | | 12,224,273 | ||
| Inventory, net | 10,401,889 | | 12,821,194 | ||
| Prepaid expenses and other current assets | 2,049,690 | | 1,193,447 | ||
| Total current assets | 75,242,219 | | 76,001,112 | ||
| Property and equipment, net | 16,810,797 | | 9,288,625 | ||
| Intangible assets, net | 3,098,691 | | 2,519,053 | ||
| Operating lease right-of-use asset | 154,688 | | 2,043,043 | ||
| Deferred tax asset, net | 2,820,468 | | 2,122,816 | ||
| Other assets | 198,912 | | 181,449 | ||
| Total assets | $98,325,775 | | $92,156,098 | ||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | | ||||
| Current liabilities: | | ||||
| Accounts payable | $1,896,405 | | $1,857,091 | ||
| Accrued payroll and benefits | 3,771,756 | | 2,775,103 | ||
| Other accrued taxes | 162,998 | | 103,241 | ||
| Warranty reserve | 118,269 | | 117,463 | ||
| Deferred revenue | 2,259,616 | | 2,570,407 | ||
| Dividend payable | | — | | | 7,975,997 |
| Current portion of operating lease liabilities | 153,264 | | 427,963 | ||
| Other current liabilities | 150,000 | | 250,000 | ||
| Accrued income taxes | — | | 250,041 | ||
| Total current liabilities | 8,512,308 | | 16,327,306 | ||
| Deferred revenue, non-current | 2,993,287 | | 2,793,548 | ||
| Operating lease liabilities, non-current | 1,424 | | 1,615,080 | ||
| Total liabilities | 11,507,019 | | 20,735,934 | ||
| Stockholders’ equity: | | ||||
| Common stock; $0.0001 par value per share; 31,500,000 shares authorized; 12,709,860 shares issued and outstanding as of December 31, 2024, and 12,660,313 shares issued and outstanding as of December 31, 2023 | 1,271 | | 1,265 | ||
| Additional paid-in capital | 30,026,734 | | 28,160,745 | ||
| Retained earnings | 56,790,751 | | 43,258,154 | ||
| Total stockholders' equity | 86,818,756 | | 71,420,164 | ||
| Total liabilities and stockholders’ equity | $98,325,775 | | $92,156,098 | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.